Literature DB >> 6263899

Specific phosphorylation of E-5-(2-iodovinyl)-2'-deoxyuridine by herpes simplex virus-infected cells.

J Descamps, E De Clercq.   

Abstract

E-5-(2-Iodovinyl)-2'-deoxyuridine (IvdUrd), a highly selective and potent anti-herpes agent, is phosphorylated by primary rabbit kidney (PRK) cells that have been infected with either herpes simplex virus type 1 (KOS) or herpes simplex virus type 2 (G). However, IvdUrd is not phosphorylated by mock-infected PRK cells or PRK cells that have been infected with a thymidine kinase-deficient mutant of herpes simplex virus type 1 (B 2006). These observations strengthen the concept that the selectivity of IvdUrd and related E-5-(2-halogenovinyl)-2'-deoxyuridines as anti-herpes agents depends on a specific phosphorylation by the virus-encoded thymidine kinase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263899

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Specific neuro-radiological diagnosis of herpes encephalitis in an animal model.

Authors:  G M Cleator; P E Klapper; A G Lewis; H L Sharma; M Longson
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cells.

Authors:  N K Ayisi; E De Clercq; R A Wall; H Hughes; S L Sacks
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

Review 3.  Specific targets for antiviral drugs.

Authors:  E De Clercq
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

4.  Susceptibility of recent clinical isolates of herpes simplex virus to 5-ethyl-2'-deoxyuridine: preferential inhibition of herpes simplex virus type 2.

Authors:  C Z Teh; S L Sacks
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

5.  Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitro.

Authors:  M J Gill; J Samuel; L I Wiebe; E E Knaus; D L Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

6.  Influence of (E)-5-(2-bromovinyl)-2'-deoxyuridine on corneal epithelium healing.

Authors:  P C Maudgal; N De Kimpe; E De Clercq; J Descamps; L Missotten; A Geysen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

7.  HM-PAO-imaging and herpes encephalitis.

Authors:  G M Cleator; A G Lewis; P E Klapper; H L Sharma; A M Smith
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Bromovinyldeoxyuridine and interferon treatment in ulcerative herpetic keratitis: a double masked study.

Authors:  O P van Bijsterveld; P J Meurs; E de Clercq; P C Maudgal
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

9.  Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo.

Authors:  C Desgranges; G Razaka; F Drouillet; H Bricaud; P Herdewijn; E De Clercq
Journal:  Nucleic Acids Res       Date:  1984-02-24       Impact factor: 16.971

10.  Enhanced delivery of 5-iodo-2'-deoxyuridine to the brain parenchyma.

Authors:  M K Ghosh; A K Mitra
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.